(2002). Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury.
(1984). Increased microvascular permeability in dog lungs due to high peak airway pressures.
(2009). Management of acute lung injury and acute respiratory distress syndrome in children.
(2002). Mechanical ventilation with permissive hypercapnia increases intrapulmonary shunt in septic and nonseptic patients with acute respiratory distress syndrome.
(2002). Metaanalysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes.
(2000). Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome.
(2007). Permissive range of hypercapnia for improved peripheral microcirculation and cardiac output in rabbits.
(2001). Protective effects of hypercapnic acidosis on ventilator-induced lung injury.
(2009). Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study.
(2007). Pumpless extracorporeal lung assist for protective mechanical ventilation in experimental lung injury.
(2009). Pumpless extracorporeal removal of carbon dioxide combined with ventilation using low tidal volume and high positive end-expiratory pressure in a patient with severe acute respiratory distress syndrome.
(2001). Spontaneous breathing during partial liquid ventilation in animals with meconium aspiration.
(2008). Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury.
(1997). Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS.
(2000). The Acute Respiratory Distress Syndrome Network
(2009). Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats.
(1994). Tidal ventilation at low airway pressures can augment lung injury.
(2009). Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal.
(2001). Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factorkappaB and is blocked by steroids.